GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BioCorRx Inc (OTCPK:BICX) » Definitions » Long-Term Capital Lease Obligation

BICX (BioCorRx) Long-Term Capital Lease Obligation : $0.15 Mil (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is BioCorRx Long-Term Capital Lease Obligation?

BioCorRx's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.15 Mil.

BioCorRx's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 ($0.17 Mil) to Dec. 2024 ($0.16 Mil) and declined from Dec. 2024 ($0.16 Mil) to Mar. 2025 ($0.15 Mil).

BioCorRx's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($0.18 Mil) to Dec. 2023 ($0.01 Mil) but then increased from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.16 Mil).


BioCorRx Long-Term Capital Lease Obligation Historical Data

The historical data trend for BioCorRx's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCorRx Long-Term Capital Lease Obligation Chart

BioCorRx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.32 0.18 0.01 0.16

BioCorRx Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.18 0.17 0.16 0.15

BioCorRx  (OTCPK:BICX) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

BioCorRx Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of BioCorRx's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


BioCorRx Business Description

Traded in Other Exchanges
N/A
Address
2390 East Orangewood Avenue, Suite 500, Anaheim, CA, USA, 92806
BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders. The BioCorRx Recovery Program is a non-addictive, medication assisted treatment program for substance abuse that includes peer recovery support. The UnCraveRx Weight Loss Management Program is a medically assisted weight management program that is combined with a virtual platform application.
Executives
Louis C. Lucido director 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Joseph J Galligan director, 10 percent owner 333 SOUTH GRAND AVENUE, 18TH FLOOR, LOS ANGELES CA 90071
Harsha Murthy director 5209 38TH STREET,NW, WASHINGTON DC 20015
Luisa Ingargiola director 4826 BLUE JAY CIRCLE, PALM HARBOR FL 34683
Thomas Patrick Welch officer: Vice President of Operations 10453 SARAH ST., TOLUCA LAKE CA 91602
Kent Emry director, officer: Chief Executive Officer 2390 EAST ORANGEWOOD AVENUE, SUITE 500, ANAHEIM CA 92806
Brady James Granier director 13024 DELANO STREET, VALLEY GLEN CA 91401
Lourdes Felix director, officer: Chief Financial Officer 15 CALLE VERANO, RANCHO SANTA MARGARITA CA 92688
Jorge Jr Andrade director, officer: Chief Executive Officer PO BOX 5366, SANTA ANA CA 92704
Muller Neil Terrence Mr director, officer: President 13231 SANDHURST PLACE, SANTA ANA CA 92705

BioCorRx Headlines

From GuruFocus

BioCorRx Provides Business Update for the Third Quarter of 2022

By Value_Insider Value_Insider 11-15-2022

BioCorRx to Present at the LD Micro Invitational XII on June 7th

By GuruFocusNews GuruFocusNews 06-30-2022

BioCorRx Appoints Pharmaceutical & Finance Veteran Harsha Murthy to the Board of Directors

By Stock market mentor Stock market mentor 01-24-2023

BioCorRx to Present at the LD Micro Invitational XII on June 7th

By GuruFocusNews GuruFocusNews 07-10-2022